Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells-Reference-Cited by-同舟云学术

Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells

Published:2014-06-27 Issue:6 Volume:9 Page:e100091
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pritchett James,Athwal Varinder S.,Harvey Emma,Martin Katherine,Llewellyn Jessica,Ireland Philip,Nicolaides Alexander,Humphries Martin J.,Bobola Nicoletta,Hanley Neil A.,Piper Hanley Karen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Current status of novel antifibrotic therapies in patients with chronic liver disease;M Cohen-Naftaly;Therap Adv Gastroenterol,2011

2. Therapy for fibrotic diseases: nearing the starting line;SL Friedman;Sci Transl Med,2013

3. Mechanisms of hepatic fibrogenesis;SL Friedman;Gastroenterology,2008

4. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ;JP Iredale;J Clin Invest,2007

5. Understanding the role of SOX9 in acquired diseases: lessons from development;J Pritchett;Trends Mol Med,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cordycepin alleviates diabetes mellitus-associated hepatic fibrosis by inhibiting SOX9-mediated Wnt/β-catenin signal axis;Bioorganic Chemistry;2024-12

2. SOX9-regulated matrix proteins predict poor outcomes in patients with COVID-19 and pulmonary fibrosis;2024-01-23

3. Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-14

4. PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis;Cell Reports;2023-11

5. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases;Genes & Diseases;2023-06